EMT or LPN/LVN or RN
GRIFOLS, S.A.
Summary
Perform physical examination and establish medical history to determine donor suitability
Job description
Build rapport with donors to ensure overall customer satisfaction
Ensure donor and staff confidentiality
Responsible for donor awareness to potential hazards
Provide donor education regarding general health and provide counseling regarding unacceptable test results
Evaluate & manage donor injuries and adverse events
Perform evaluations of any history of illness or medications to ensure continued donor suitability
Assist in employee training
Administer employee Hepatitis Vaccine program
Requirements
- Educated and currently certified/licensed in the state of employment and according to state requirements as a Registered Nurse, Licensed Practical Nurse, Licensed Vocational Nurse, Paramedic, or EMT.
- Current CPR certification required.
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Tuition Reimbursement
- Paid Time Off
- Holiday Pay
- Company Bonus Program
Company overview
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines, founded in Barcelona, Spain in 1909. As the European leader and third largest plasma-derived medicine manufacturer worldwide, Grifols specializes in developing, producing, and marketing essential plasma-derived protein therapies for patients suffering from rare, chronic, and life-threatening conditions. The company operates across four main business units: Biopharma (plasma-derived medicines), Diagnostic (transfusion medicine and clinical diagnostics), Bio Supplies (biological materials for research), and Healthcare Solutions for Hospitals. With over 23,800 employees serving more than 110 countries, Grifols maintains 15 industrial facilities across seven countries and operates approximately 400 plasma donation centers globally. The company focuses on therapeutic areas including immunology, infectious diseases, pulmonology, hematology, hepatology, intensive care, and neurology, with more than 1,200 researchers working across 12 R&D centers worldwide. Grifols is publicly traded on both the Madrid Stock Exchange (GRF) and NASDAQ (GRFS), generating approximately €7.2 billion in annual revenue.